The stock of Kala Bio Inc (KALA) has gone up by 30.17% for the week, with a 52.17% rise in the past month and a 68.45% rise in the past quarter. The volatility ratio for the week is 11.67%, and the volatility levels for the past 30 days are 12.02% for KALA. The simple moving average for the past 20 days is 34.39% for KALA’s stock, with a 7.16% simple moving average for the past 200 days.
Is It Worth Investing in Kala Bio Inc (NASDAQ: KALA) Right Now?
Moreover, the 36-month beta value for KALA is -1.85. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for KALA is 5.24M and currently, short sellers hold a 5.66% of that float. On July 10, 2025, KALA’s average trading volume was 71.34K shares.
KALA) stock’s latest price update
The stock of Kala Bio Inc (NASDAQ: KALA) has increased by 22.09% when compared to last closing price of $5.16.Despite this, the company has seen a gain of 30.17% in its stock price over the last five trading days. globenewswire.com reported 2025-07-09 that — Topline results from the CHASE trial expected by end of Q3 2025 — — Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on positive results —
Analysts’ Opinion of KALA
Jefferies gave a rating of “Hold” to KALA, setting the target price at $10 in the report published on September 14th of the previous year.
KALA Trading at 52.48% from the 50-Day Moving Average
After a stumble in the market that brought KALA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.75% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KALA starting from Kharabi Darius, who sale 4,511 shares at the price of $4.01 back on Jun 24 ’25. After this action, Kharabi Darius now owns 62,566 shares of Kala Bio Inc, valued at $18,089 using the latest closing price.
Reumuth Mary, the CHIEF FINANCIAL OFFICER of Kala Bio Inc, sale 3,631 shares at $4.01 during a trade that took place back on Jun 24 ’25, which means that Reumuth Mary is holding 62,100 shares at $14,560 based on the most recent closing price.
Stock Fundamentals for KALA
The total capital return value is set at -1.57. Equity return is now at value -576.46, with -70.40 for asset returns.
Based on Kala Bio Inc (KALA), the company’s capital structure generated 0.75 points at debt to capital in total, while cash flow to debt ratio is standing at -1.59. The debt to equity ratio resting at 3.02. The interest coverage ratio of the stock is -12.27.
Currently, EBITDA for the company is -40.98 million with net debt to EBITDA at 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.99.
Conclusion
To wrap up, the performance of Kala Bio Inc (KALA) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
